Your browser doesn't support javascript.
loading
Management of Primary Hyperparathyroidism.
Bilezikian, John P; Silverberg, Shonni J; Bandeira, Francisco; Cetani, Filomena; Chandran, Manju; Cusano, Natalie E; Ebeling, Peter R; Formenti, Anna Maria; Frost, Morten; Gosnell, Jessica; Lewiecki, E Michael; Singer, Frederick R; Gittoes, Neil; Khan, Aliya A; Marcocci, Claudio; Rejnmark, Lars; Ye, Zhikang; Guyatt, Gordon; Potts, John T.
Afiliación
  • Bilezikian JP; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Silverberg SJ; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Bandeira F; Division of Endocrinology, University of Pernambuco Medical School Recife, Recife, Brazil.
  • Cetani F; Endocrine Unit 2, University Hospital of Pisa, Pisa, Italy.
  • Chandran M; Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
  • Cusano NE; Division of Endocrinology, Department of Medicine, Lenox Hill Hospital, New York, NY, USA.
  • Ebeling PR; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
  • Formenti AM; Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS Hospital, Milan, Italy.
  • Frost M; Bone and Calcium Unit & Molecular Endocrinology Unit, Department of Endocrinology, Odense University Hospital, Odense, Denmark.
  • Gosnell J; Department of Surgery, University of California, San Francisco, CA, USA.
  • Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
  • Singer FR; Endocrine/Bone Disease Program, Saint John's Cancer Institute, Santa Monica, CA, USA.
  • Gittoes N; Centre for Endocrinology, Diabetes and Metabolism, Queen Elizabeth Hospital and University of Birmingham, Birmingham, UK.
  • Khan AA; Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada.
  • Marcocci C; Department of Clinical and Experimental Medicine, University of Pisa, Endocrine Unit 2, University Hospital of Pisa, Pisa, Italy.
  • Rejnmark L; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Ye Z; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  • Guyatt G; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  • Potts JT; Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
J Bone Miner Res ; 37(11): 2391-2403, 2022 11.
Article en En | MEDLINE | ID: mdl-36054638
Since the last international guidelines were published in 2014 on the evaluation and management of primary hyperparathyroidism (PHPT), new information has become available with regard to evaluation, diagnosis, epidemiology, genetics, classical and nonclassical manifestations, surgical and nonsurgical approaches, and natural history. To provide the most current summary of these developments, an international group, consisting of over 50 experts in these various aspects of PHPT, was convened. This paper provides the results of the task force that was assigned to review the information on the management of PHPT. For this task force on the management of PHPT, two questions were the subject of systematic reviews using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) methodology. The full report addressing surgical and nonsurgical management of PHPT, utilizing the GRADE methodology, is published separately in this series. In this report, we summarize the results of that methodological review and expand them to encompass a much larger body of new knowledge that did not specifically fit the criteria of the GRADE methodology. Together, both the systematic and narrative reviews of the literature, summarized in this paper, give the most complete information available to date. A panel of experts then considered the last set of international guidelines in light of the newer data and assessed the need for their revision. This report provides the evidentiary background to the guidelines report. In that report, evidence from all task forces is synthesized into a summary statement and revised guidelines for the evaluation and management of PHPT. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperparatiroidismo Primario Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: J Bone Miner Res Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperparatiroidismo Primario Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: J Bone Miner Res Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos